Phagocytic removal of apoptotic cells occurs efficiently in vivo such that even in tissues with significant apoptosis, very few apoptotic cells are detectable 1 . This is thought to be due to the release of 'find-me' signals by apoptotic cells that recruit motile phagocytes such as monocytes, macrophages and dendritic cells, leading to the prompt clearance of the dying cells 2 . However, the identity and in vivo relevance of such find-me signals are not well understood. Here, through several lines of evidence, we identify extracellular nucleotides as a critical apoptotic cell find-me signal. We demonstrate the caspase-dependent release of ATP and UTP (in equimolar quantities) during the early stages of apoptosis by primary thymocytes and cell lines. Purified nucleotides at these concentrations were sufficient to induce monocyte recruitment comparable to that of apoptotic cell supernatants. Enzymatic removal of ATP and UTP (by apyrase or the expression of ectopic CD39) abrogated the ability of apoptotic cell supernatants to recruit monocytes in vitro and in vivo. We then identified the ATP/UTP receptor P2Y 2 as a critical sensor of nucleotides released by apoptotic cells using RNA interference-mediated depletion studies in monocytes, and macrophages from P2Y 2 -null mice 3 . The relevance of nucleotides in apoptotic cell clearance in vivo was revealed by two approaches. First, in a murine air-pouch model, apoptotic cell supernatants induced a threefold greater recruitment of monocytes and macrophages than supernatants from healthy cells did; this recruitment was abolished by depletion of nucleotides and was significantly decreased in P2Y 2 2/2 (also known as P2ry2 2/2 ) mice. Second, clearance of apoptotic thymocytes was significantly impaired by either depletion of nucleotides or interference with P2Y receptor function (by pharmacological inhibition or in P2Y 2 2/2 mice). These results identify nucleotides as a critical find-me cue released by apoptotic cells to promote P2Y 2 -dependent recruitment of phagocytes, and provide evidence for a clear relationship between a find-me signal and efficient corpse clearance in vivo.
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Most developing thymocytes (95%) undergo apoptosis, but in the steady state only 1-2% are detectable as apoptotic 4, 5 . It has been speculated that dying thymocytes secrete soluble factors that attract resident phagocytes to promote prompt clearance 2, 6 . To determine whether apoptotic thymocytes release such factors, we assessed cellfree supernatants after apoptosis induction (by anti-Fas/CD95 crosslinking) for their ability to attract THP-1 monocytes or primary human monocytes in a transwell migration assay ( Fig. 1a and Supplementary Fig. 2 ). Apoptotic supernatants caused a threefold increase in monocyte migration than supernatants from live thymocytes did. This release of chemotactic factors was also seen with Jurkat cells (a mature T-cell line) induced to undergo Fas-mediated or ultraviolet-mediated apoptosis (Fig. 1b) . There was no detectable increase in membrane permeability or leakage of cytoplasmic markers when the supernatants were collected ( Fig. 2g and Supplementary  Fig. 1a-e) . Moreover, supernatants from cells pretreated with the caspase inhibitor zVAD-fmk before the induction of apoptosis failed to induce monocyte migration (Fig. 1a, c) , suggesting caspasedependent and regulated release of chemoattractant(s). In a time course, release of chemotactic factor(s) was correlated with the onset and progression of apoptosis (assessed by annexin V binding to phosphatidylserine exposed on apoptotic cells, and caspase-3/7 activity; Fig. 1b and Supplementary Fig. 1b, c) . Last, the chemotactic factor(s) were soluble and heat-stable, because high-speed centrifugation or boiling of the supernatants did not affect the chemotactic potential ( Supplementary Fig. 3f ).
We next tested whether find-me signal(s) in apoptotic cell supernatants could attract phagocytes in vivo. We used a murine dorsal airpouch model (Fig. 1d ) in which the supernatants from apoptotic or live cells were injected into sterile, subcutaneous air-pouches 7 . When cells in the air-pouch were recovered by lavage after 24 h, apoptotic cell supernatants caused a threefold increase in the number of CD45 1 leukocytes recruited in comparison with live cell supernatants or medium alone ( Fig. 1e ; n 5 8, P 5 0.02). The total number of monocytes and macrophages (CD11b 1 /Gr-l low ) in the lavage was increased about threefold in comparison with neutrophils (Gr-1 high cells) (Fig. 1e) . By contrast, injection of bacterial lipopolysaccharide induced the recruitment of mostly Gr-1 high neutrophils (Fig. 1f) . This is consistent with previous studies on the preferential recruitment of monocyte/macrophages rather than inflammatory neutrophils to cells undergoing apoptosis 8, 9 . F4/80 1 macrophages recruited to the pouch could also engulf apoptotic Jurkat cells injected into the pouch (data not shown). These data revealed the release of find-me signal(s) by apoptotic lymphocytes that attract monocytes in vitro and in vivo.
We then sought to determine the nature of the chemoattractant. On the basis of in vitro studies, the lipid lysophosphatidylcholine was implicated as a find-me signal released by apoptotic MCF-7 cancer cells 10 . However, we did not observe monocyte migration towards purified lysophosphatidylcholine over a range of concentrations (0.1-100 mM; data not shown) under our conditions; moreover, treatment of apoptotic cell supernatants with phospholipase D, an enzyme that promotes the hydrolysis of lysophosphatidylcholine (see Supplementary Fig. 3a, b) , did not affect chemotactic activity of supernatants from apoptotic thymocytes, Jurkat cells or MCF-7 cells (Fig. 1a, j, k) . CX 3 CL1 (fractalkine) released by apoptotic Burkitt lymphoma B cells can also act as a find-me signal 11 ; however, THP-1 monocytes used here failed to show migration towards purified CX 3 CL1, and the anti-fractalkine-depleting antibody did not block migration in our assays (data not shown). Thus, the find-me signal released by apoptotic primary thymocytes and Jurkat cells seemed to be distinct from those reported previously.
Subsequently, several lines of evidence suggested a role for extracellular nucleotides as a possible find-me signal. Treatment of apoptotic cell supernatants with recombinant apyrase, an enzyme that hydrolyses nucleoside triphosphates and diphosphates to nucleoside monophosphates (for example ATPRADPRAMP), abolished the monocyte chemoattractant activity of apoptotic thymocytes, Jurkat and MCF-7 cells at all time points (Fig. 1a , g, j, k and Supplementary  Fig. 3e ). Apyrase did not affect monocyte migration towards chemokines CCL2 or CXCL12 (Fig. 1g and data not shown) . Treatment of apoptotic cell supernatants (but not CCL2) with apyrase before injection into the dorsal air-pouch also inhibited the attraction of leukocytes in vivo (Fig. 1h, i) . As another approach, we expressed in Jurkat cells the transmembrane protein CD39 (NTPDase-l), the primary mammalian ecto-apyrase responsible for NTP degradation by immune cells in vivo 12 (see Supplementary Fig. 4b ); CD39 expression abrogated the chemoattractant activity in the supernatants of apoptotic Jurkat cells (Fig. 1l ). Neither treatment with apyrase nor CD39 overexpression impaired the induction of apoptosis (see below and Supplementary Fig. 4a ). Inactivation of apyrase by heat (before addition to apoptotic cell supernatants) abolished its effect ( Fig. 1a and Supplementary Fig. 3d ), suggesting a need for intact enzymatic activity. Thus, induction of apoptosis led to an accumulation of extracellular nucleotides capable of monocyte chemoattraction in vitro and in vivo.
Among the four naturally occurring extracellular nucleotides (ATP, ADP, UTP and UDP), ATP and UTP induced strong chemotactic activity in THP-1 monocytes (Fig. 2a) ; in contrast, ADP and UDP showed partial activity at the highest concentrations tested (Fig. 2a) , but lower than that of NTPs. The migration was also stimulated by the non-hydrolysable ATP analogue ATP-cS but not by adenosine ( Supplementary Fig. 5a ), suggesting attraction primarily towards triphosphate nucleotides. When ATP and UTP levels in apoptotic cell supernatants were directly quantified (see Methods), higher ATP and UTP levels could be detected as early as 2 h after the induction of apoptosis, with a further increase by 4 h (Fig. 2b) . The concentrations of ATP and UTP at the time point when the apoptotic supernatants induced maximal monocyte migration correlated well with the concentrations at which pure ATP and UTP caused maximal migration (about 100 nM) (Figs 1b and 2a, b). The addition of pure ATP and UTP to the upper chamber of the transwell, to disrupt the gradient, blocked the migration of monocytes to the lower chamber containing apoptotic cell supernatants ( Supplementary Fig. 6a -c). Although ATP can promote chemokinesis or random migration of neutrophils 13 , the addition of pure ATP or UTP only to the upper chamber did not induce the migration of THP-1 cells to the lower chamber, indicating that the migration induced was not chemokinesis but chemotaxis ( Supplementary Fig. 6d ). Furthermore, the release of nucleotides from apoptotic cells is dependent on caspase activity, and occurs after different types of apoptosis induction (DNA damage, receptor-mediated and steroid-induced) and occurred in primary thymocytes, Jurkat and epithelial cells undergoing apoptosis; this release of ATP was also well correlated with the induction of apoptosis ( The release of ATP during apoptosis was not due to leakage of cellular contents or to mechanical stress during handling of cells 14 ( Fig. 2f, g ). Collectively, these data strongly suggested a role for ATP and UTP as find-me signals that are important for phagocyte chemoattraction by apoptotic cells.
We then addressed how the phagocytes might 'sense' the extracellular nucleotides as a find-me cue. Leukocyte migration towards nucleotides has been shown to be dependent on members of the P2Y family of G-protein-coupled receptors 15, 16 . We tested the role of P2Y receptors on monocytes and macrophages in migration towards apoptotic cell supernatants. First, pretreatment of THP-l cells with suramin, a non-selective inhibitor of P2 family members, showed dose-dependent inhibition of migration towards apoptotic supernatants but not towards CCL2 (Fig. 3a and Supplementary  Fig. 5c ). After several P2Y family members were evaluated through known antagonists (scored by inhibition of migration towards apoptotic cell supernatants), we focused on P2Y 2 based on its known affinities for ATP and UTP (because both are released by apoptotic cells), and the P2Y 2 expression on monocytes and macrophages 16 . Although P2Y 4 also fits the profile for ATP and UTP binding, THP-1 cells express no detectable P2Y 4 but strongly express P2Y 2 mRNA (ref. 17 and data not shown). Short interfering RNA (siRNA)-mediated knockdown of P2Y 2 in THP-1 monocytes led to a 60% decrease in P2Y 2 mRNA and also partly inhibited migration towards apoptotic cell supernatants (10.5% 6 0.8% versus 16.3% 6 2.0% (means 6 s.e.m.) for control siRNA; n 5 6, P 5 0.003), but did not affect migration towards CCL2 or CXCL12 (Fig. 3b and data not  shown) . Bone-marrow-derived macrophages (BMDMs) from P2Y 2 2/2 mice 3 showed impaired migration towards apoptotic supernatants, but their migration towards CXCL12 was intact (Fig. 3c) . When apoptotic cell supernatants were injected into the air-pouch of P2Y 2 -deficient mice, there was a strong decrease in the recruitment of monocytes and macrophages to the pouch, indicating in vivo relevance of this receptor in sensing the find-me signal (Fig. 3d ). Although P2Y 6 was shown to have a function in UDP-dependent leukocyte migration 15, 18 and phagocytosis by microglial cells 19 , neither RNA-mediated interference towards P2Y 6 nor towards the P2Y 6 antagonist MRS2578 showed specific inhibition of migration ( Supplementary Fig. 5b and data not shown) Finally, addition of antagonists to the adenosine receptors A1, A2a and A3 (refs 13, 20) or the A2 receptor agonist CGS21680 did not significantly affect the migration of monocytes to the apoptotic cell supernatants (Fig. 3e and Supplementary Fig. 5d ). Moreover, adenosine itself did not induce migration of THP-1 cells, and addition of exogenous adenosine did not affect migration towards apoptotic cell supernatants ( Supplementary Fig. 5a, d ). Taken together, these results identify the P2Y 2 receptor on monocytes and macrophages as a critical sensor of the find-me signal released by apoptotic cells.
As a further test of the importance of nucleotides as a find-me signal in an in vivo model of apoptosis, we used intraperitoneal injection of dexamethasone, in which a large fraction of immature thymocytes undergo largely synchronous apoptosis and phagocytic clearance 5, 21 . Dexamethasone injection induced thymic apoptosis, with a decline in thymus size and cellularity within 4 h, and a decrease to less than half that of control-treated mice by 8 h (Fig. 4a) . Treatment of thymocytes with dexamethasone in vitro also induced apoptosis in a large fraction of the cells by 4 h (more than 40%) and 6 h (more than 60%) (Fig. 4g) . We examined whether apyrasemediated destruction of nucleotides in vivo could influence the apoptosis and clearance of dexamethasone-mediated thymocytes. Injection of apyrase significantly reversed the decline in thymus size and cellularity resulting from dexamethasone treatment (especially at 6 h) (Fig. 4a) . This was not due to an effect of apyrase on the apoptotic process itself, because the fraction of cells undergoing apoptosis as a result of dexamethasone treatment was unchanged on treatment with apyrase in vivo or in vitro (Fig. 4e, g ). The total numbers of apoptotic cells remaining at 6 and 8 h were greater in mice treated with apyrase plus dexamethasone than in those treated with dexamethasone alone (Fig. 4b) . Because apyrase had no effect on the phagocytic capacity of macrophages ( Supplementary Fig. 9 ), apyrase-mediated destruction of the nucleotide find-me signal seemed to affect phagocyte recruitment, and in turn to delay clearance. In a complementary set of studies, we tested how a disruption to the 'sensing' of the find-me signal affected apoptotic cell clearance. Injection of the P2Y inhibitor suramin before dexamethasone reversed the diminution of the thymic cellularity and organ size seen with dexamethasone alone (Fig. 4c, d) . The total number of apoptotic thymocytes also increased in suramin plus dexamethasone conditions (Fig. 4d) . As with apyrase, suramin itself did not alter the induction of thymocyte apoptosis (Fig. 4f, g ). When we assessed the presence of apoptotic cells in the native thymic architecture (by immunohistochemistry with antibody against single-stranded DNA), there were greater numbers of uncleared apoptotic cells after treatment with suramin plus dexamethasone than after treatment with dexamethasone alone (Supplementary Fig. 10 ). We also assessed whether genetic disruption of the putative find-me signal receptor P2Y 2 would affect apoptotic cell clearance in vivo. After injection of dexamethasone, the number of apoptotic thymocytes in the thymuses of P2Y 2 2/2 mice was significantly greater than in control mice (Fig. 4h) . Taken together, these results show that the disruption of a find-me signal circuit at the level of nucleotides or the sensing receptor significantly impairs the clearance of apoptotic thymocytes, without an apparent effect on the induction of apoptosis or engulfment.
The data presented here provide new insights into particular aspects of the apoptotic cell death process. First, this work identifies ATP and UTP as a critical and non-redundant find-me signal released by apoptotic cells, documenting the regulated and caspase-dependent release of nucleotides from apoptotic cells with a functional secondary consequence. Because nucleotide release is seen in primary cells and cell lines (after different types of apoptotic stimulus), nucleotides may be a broadly used find-me signal. However, these data do not exclude the possibility of other chemotactic factors that work alone or together with nucleotides. Second, these data establish a clear relationship between a find-me signal and efficient apoptotic cell clearance in vivo; the disruption of the find-me signal circuit at the level of ATP/UTP or the receptors (P2Y) impaired the clearance of apoptotic thymocytes. Although we focused here on motile monocytes/macrophages, genetic studies in Caenorhabditis elegans, in which healthy cells engulf the dying neighbours, have revealed a link between apoptosis and engulfment 22, 23 . How nucleotides might regulate engulfment by neighbouring non-professional phagocytes 6, 24 remains to be determined. Extracellular nucleotides at higher concentrations are considered pro-inflammatory 25 (more than 1 mM, for example, by necrotic cells; Supplementary Fig. 7 ), but nucleotides can also induce an antiinflammatory response 26 . Besides serving as a find-me signal, it remains to be determined whether nucleotides participate in antiinflammatory signalling during engulfment. It has recently been shown that lactoferrin released by apoptotic cells inhibits neutrophil migration 27 . How nucleotides and lactoferrin concurrently promote monocyte migration while inhibiting neutrophil migration remains to be seen. Because a failure to clear dying cells promptly can lead to autoimmunity and chronic inflammatory diseases 9 , phagocyte chemoattraction to apoptotic cells by means of nucleotides may have implications for human disease states related to failed clearance.
METHODS SUMMARY
Supernatant preparation. Jurkat (E6-1) cells at 2 3 10 6 ml 21 in RPMI medium containing 5% heat-inactivated FBS and 10 mM HEPES, pH 7.2 were treated with 250 ng ml 21 anti-Fas (CH11) or 100 mJ cm 22 of ultraviolet-C. Freshly isolated thymocytes from 4-5-week-old C57BL/6 mice were treated at 5 3 10 6 ml 21 with crosslinked anti-Fas (5 mg ml 21 Jo2, 2 mg ml 21 protein G) in RPMI containing 1% BSA and 10 mM HEPES, pH 7.2. Supernatants were collected by two successive centrifugations at 500g for 4 min at 4 uC. Pretreatment with zVAD-fmk (50 mM) and treatment of supernatants with apyrase (0.025 U ml
21
) and phospholipase D (0.5 U ml
) was performed for 5 min at room temperature (25 uC). MCF-7 supernatants were prepared as described previously 10 . Migration assays. THP-1 cells at 2 3 10 6 ml 21 were placed for 1 h on a 5-mm pore-size Transwell with chemoattractant. Percentage migration was determined by flow cytometry with AccuCount beads. For migration of BMDMs, 5 3 10 4 d7 BMDM cells were placed on a 5-mm pore-size Transwell and incubated for 2 h with Jurkat supernatants in RPMI containing 1% BSA and 10 mM HEPES, pH 7.2 in the lower chamber; migration was determined by Diff-Quick staining and microscopy. In vivo experiments. Air-pouch experiments were performed as described 7 , with 8-12-week old C57BL/6 mice injected with 1 ml of 0.2-mm-filtered supernatants. After 24 h, the pouch was lavaged and cells were counted and analysed by flow cytometry. For thymic clearance studies, 4-5-week-old C57BL/6 mice were injected intraperitoneally with 250 mg dexamethasone and 5 U apyrase at the ) and suramin (100 mM) do not affect dexamethasone-induced thymocyte apoptosis in vitro. zVAD-fmk (zVAD) was included as a control. The percentage apoptotic cells is shown. h, Left: paraffin-embedded sections from thymuses of wild-type and P2Y 2 2/2 mice treated with dexamethasone for 6 h (brown, Apostain; blue, haematoxylin). Right: mean number of Apostain-positive nuclei per field from 10-16 random fields per section per mouse. Asterisk, P 5 0.001. Error bars indicate s.e.m. throughout. midpoint of dexamethasone treatment, and with 6 mg suramin 1 h before dexamethasone injection. Thymocytes were stained with annexin V and propidium iodide and beads were added for quantification by flow cytometry. For in situ apoptotic cell detection, thymuses from female P2Y 2 2/2 or agematched C57BL/6 mice were stained by Apostain as described 28 . Nucleotide measurement. ATP was measured by luciferase reaction as described 29 . UTP was quantified by the UDP-glucose pyrophosphorylase-based reaction 30 . Measurements were conducted on supernatants prepared from cells cultured in RPMI containing 1% BSA and 10 mM HEPES, pH 7.2.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
